The Molbio Diagnostics IPO entered its second day with strong investor interest, as the grey market premium (GMP) climbed to 17% from 15% earlier. The issue was subscribed 83% on Day 1, with retail investors subscribing to 77% of their quota. The Rs 939.70-crore IPO comprises a Rs 200-crore fresh issue and Rs 739.70 crore OFS.
The Molbio Diagnostics IPO entered its second day with strong investor interest, as the grey market premium (GMP) climbed to 17% from 15% earlier. The issue was subscribed 83% on Day 1, with retail investors subscribing to 77% of their quota. The Rs 939.70-crore IPO comprises a Rs 200-crore fresh issue and Rs 739.70 crore OFS.
<iframe src="https://hindustansphere.com/embed/cluster/f41421eb078231f3fec6f30b3398dc5377dcc9b8" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Molbio IPO Day 2: GMP hits at 17% listing gains. Should you bid?"></iframe>
